NAUTILUS BIOTECHNOLOGY INC (NAUT) Stock Earnings & Estimates
USA - NASDAQ:NAUT - US63909J1088 - Common Stock
1.8 USD
-0.09 (-4.76%)
1.85 USD
+0.05 (+2.78%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 600.00% | N/A 177.14% | N/A 126.12% | |||||||
| EBITDA YoY % growth | -9.56M | -15.03M -57.22% | -49.48M -229.21% | -62.4M -26.11% | -74.303M -19.08% | -79.501M -7.00% | N/A 12.24% | N/A -21.49% | N/A -10.71% | N/A 0.33% | N/A 7.42% | |
| EBIT YoY % growth | -10.11M | -15.74M -55.69% | -50.5M -220.84% | -63.62M -25.98% | -76.152M -19.70% | -81.476M -6.99% | N/A 2.60% | N/A -19.15% | N/A -4.53% | N/A 1.03% | N/A 7.51% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -0.47 21.23% | -0.52 -10.64% | -0.56 -7.69% | N/A 8.93% | N/A -22.00% | N/A -3.28% | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 -2.00% | -0.17 -29.46% | -0.15 -27.50% | -0.19 -76.18% | -0.16 -14.29% |
| Revenue Q2Q % growth | 2.55M | ||||
| EBITDA Q2Q % growth | -18.462M -2.54% | -19.482M -6.00% | -22.44M -38.73% | -22.848M -61.77% | -23.664M -28.18% |
| EBIT Q2Q % growth | -19.992M -0.06% | -20.91M -10.96% | -23.868M -39.60% | -24.174M -56.24% | -25.092M -25.51% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.11 15.38% | -0.15 | 0.04 | 28.10% |
| Q2 2025 Q2Q % growth | -0.12 14.29% | -0.16 | 0.04 | 24.10% |
| Q1 2025 Q2Q % growth | -0.13 13.33% | -0.15 | 0.02 | 13.06% |
| Q4 2024 Q2Q % growth | -0.14 | -0.17 | 0.03 | 15.27% |
| Q3 2024 Q2Q % growth | -0.13 | -0.17 | 0.04 | 22.76% |
| Q2 2024 Q2Q % growth | -0.14 -7.69% | -0.17 | 0.03 | 16.31% |
| Q1 2024 Q2Q % growth | -0.15 -25.00% | -0.17 | 0.02 | 9.50% |
| Q4 2023 Q2Q % growth | -0.14 -27.27% | -0.15 | 0.01 | 5.34% |
| Q3 2023 Q2Q % growth | -0.13 -18.18% | -0.17 | 0.04 | 23.91% |
| Q2 2023 Q2Q % growth | -0.13 -8.33% | -0.15 | 0.02 | 15.03% |
| Q1 2023 Q2Q % growth | -0.12 7.69% | -0.17 | 0.05 | 29.41% |
| Q4 2022 Q2Q % growth | -0.11 15.38% | -0.16 | 0.05 | 29.67% |
| Q3 2022 Q2Q % growth | -0.11 8.33% | -0.15 | 0.04 | 26.89% |
| Q2 2022 Q2Q % growth | -0.12 36.84% | -0.17 | 0.05 | 29.76% |
| Q1 2022 Q2Q % growth | -0.13 | -0.16 | 0.03 | 18.65% |
| Q4 2021 Q2Q % growth | -0.13 | -0.14 | 0.01 | 3.81% |
| Q3 2021 Q2Q % growth | -0.12 | -0.10 | -0.02 | -17.65% |
| Q2 2021 Q2Q % growth | -0.19 | -0.07 | -0.12 | -166.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | 255K | -255K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 9.68% | 9.68% | 12.28% | 16.67% |
| Revenue | N/A | N/A | N/A | N/A |